Innovassynth [INOVSYNTH] vs Balaji Amines [BALAMINES] Detailed Stock Comparison
Innovassynth
BSE
Loading...
Balaji Amines
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Innovassynth wins in 3 metrics, Balaji Amines wins in 10 metrics, with 0 ties. Balaji Amines appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Innovassynth | Balaji Amines | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 140.85 | 32.74 | Balaji Amines |
| Price-to-Book Ratio | 7.04 | 2.70 | Balaji Amines |
| Debt-to-Equity Ratio | 10.41 | 0.55 | Balaji Amines |
| PEG Ratio | N/A | -2.68 | N/A |
| EV/EBITDA | -77.84 | 22.04 | Innovassynth |
| Profit Margin (TTM) | 0.00% | 11.11% | Balaji Amines |
| Operating Margin (TTM) | 0.00% | 11.36% | Balaji Amines |
| EBITDA Margin (TTM) | N/A | 11.36% | N/A |
| Return on Equity | -11.10% | 7.80% | Balaji Amines |
| Return on Assets (TTM) | -9.65% | 6.99% | Balaji Amines |
| Free Cash Flow (TTM) | $-7.26M | $685.60M | Balaji Amines |
| Dividend Yield | N/A | 0.65% | N/A |
| 1-Year Return | 142.10% | -29.74% | Innovassynth |
| Price-to-Sales Ratio (TTM) | N/A | 3.64 | N/A |
| Enterprise Value | $3.08B | $48.95B | Balaji Amines |
| EV/Revenue Ratio | N/A | 3.57 | N/A |
| Gross Profit Margin (TTM) | N/A | 40.84% | N/A |
| Revenue per Share (TTM) | N/A | $423 | N/A |
| Earnings per Share (Diluted) | $-1.79 | $47.01 | Balaji Amines |
| Beta (Stock Volatility) | 0.06 | 0.61 | Innovassynth |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Innovassynth vs Balaji Amines Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Innovassynth | -0.54% | -5.33% | -15.92% | 18.45% | 34.30% | 7.84% |
| Balaji Amines | -1.91% | -0.71% | -11.23% | 7.03% | 10.31% | -15.04% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Innovassynth | 142.10% | 273.23% | 1,412.05% | 1,064.73% | 833.95% | 833.95% |
| Balaji Amines | -29.74% | -56.63% | 73.43% | 1,106.30% | 3,794.26% | 5,290.57% |
Performance & Financial Health Analysis: Innovassynth vs Balaji Amines
| Metric | INOVSYNTH | BALAMINES |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.97B | ₹49.87B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 27,936 | 27,734 |
| 90 Day Avg. Volume | 35,248 | 61,248 |
| Last Close | ₹100.40 | ₹1,532.00 |
| 52 Week Range | ₹34.56 - ₹139.85 | ₹1,127.55 - ₹2,433.00 |
| % from 52W High | -28.21% | -37.03% |
| All-Time High | ₹139.85 (Aug 06, 2025) | ₹5,223.55 (Sep 13, 2021) |
| % from All-Time High | -28.21% | -70.67% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | -0.07% |
| Quarterly Earnings Growth | N/A | -0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.11% |
| Operating Margin (TTM) | 0.00% | 0.11% |
| Return on Equity (TTM) | -0.11% | 0.08% |
| Debt to Equity (MRQ) | 10.41 | 0.55 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹15.06 | ₹569.45 |
| Cash per Share (MRQ) | ₹0.02 | ₹108.10 |
| Operating Cash Flow (TTM) | ₹-42,662,000 | ₹2.65B |
| Levered Free Cash Flow (TTM) | ₹-46,874,000 | ₹1.58B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.65% |
| Last 12-Month Dividend | N/A | ₹11.00 |
Valuation & Enterprise Metrics Analysis: Innovassynth vs Balaji Amines
| Metric | INOVSYNTH | BALAMINES |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 140.85 | 32.74 |
| Forward P/E | N/A | 20.18 |
| PEG Ratio | N/A | -2.68 |
| Price to Sales (TTM) | N/A | 3.64 |
| Price to Book (MRQ) | 7.04 | 2.70 |
| Market Capitalization | ||
| Market Capitalization | ₹2.97B | ₹49.87B |
| Enterprise Value | ₹3.08B | ₹48.95B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | N/A | 3.57 |
| Enterprise to EBITDA | -77.84 | 22.04 |
| Risk & Other Metrics | ||
| Beta | 0.06 | 0.61 |
| Book Value per Share (MRQ) | ₹15.06 | ₹569.45 |
Financial Statements Comparison: Innovassynth vs Balaji Amines
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | INOVSYNTH | BALAMINES |
|---|---|---|
| Revenue/Sales | ₹0 | ₹3.58B |
| Cost of Goods Sold | ₹0 | ₹2.12B |
| Gross Profit | ₹0 | ₹1.46B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-880,000 | ₹407.22M |
| EBITDA | ₹41.03M | ₹637.15M |
| Pre-Tax Income | ₹39.83M | ₹490.13M |
| Income Tax | ₹0 | ₹124.86M |
| Net Income (Profit) | ₹39.83M | ₹365.27M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | INOVSYNTH | BALAMINES |
|---|---|---|
| Cash & Equivalents | ₹530,000 | ₹1.49B |
| Total Current Assets | ₹687,000 | ₹9.41B |
| Total Current Liabilities | ₹63.55M | ₹1.30B |
| Long-Term Debt | N/A | ₹18.83M |
| Total Shareholders Equity | ₹422.42M | ₹20.18B |
| Retained Earnings | N/A | ₹16.46B |
| Property, Plant & Equipment | N/A | ₹4.14M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | INOVSYNTH | BALAMINES |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | INOVSYNTH | BALAMINES |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 27,936 | 27,734 |
| Average Daily Volume (90 Day) | 35,248 | 61,248 |
| Shares Outstanding | 27.98M | 32.40M |
| Float Shares | 15.01M | 9.86M |
| % Held by Insiders | 0.55% | 0.68% |
| % Held by Institutions | 0.03% | 0.03% |
Dividend Analysis & Yield Comparison: Innovassynth vs Balaji Amines
| Metric | INOVSYNTH | BALAMINES |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹11.00 |
| Last 12-Month Dividend Yield | N/A | 0.65% |
| 3-Year Avg Annual Dividend | N/A | ₹10.67 |
| 3-Year Avg Dividend Yield | N/A | 0.51% |
| 3-Year Total Dividends | N/A | ₹32.00 |
| Ex-Dividend Date | N/A | Aug 01, 2025 |